Gaël Champier
Vorstandsvorsitzender bei B Cell Design SAS
Profil
Gaël Champier founded B Cell Design SAS, where they worked as Chief Executive Officer.
Dr. Champier also currently works at ArkAb SAS, as Chief Executive Officer & Director from 2018.
Dr. Champier received their graduate degree from Université de Limoges.
Aktive Positionen von Gaël Champier
| Unternehmen | Position | Beginn |
|---|---|---|
B Cell Design SAS
 B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services B Cell Design SAS provides pharmaceutical services. It offers research and development services in producing antibodies. The firm serves as a platform for other diagnostic and pharmaceutical companies addressed to academic laboratories and industrial research. The company was founded in December 7, 2007 and is headquartered in Limoges, France. | Vorstandsvorsitzender | - |
ArkAb SAS
 ArkAb SAS Medical SpecialtiesHealth Technology Part of Inoviem Scientific SAS, ArkAb SAS develops, manufactures, and commercializes raw materials for research in immunology and in vitro diagnostic market. The company is based in Limoges, France. The French company was founded in 2018. The CEO is Gaël Champier. | Vorstandsvorsitzender | 13.01.2018 |
Ausbildung von Gaël Champier
| Université de Limoges | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
ArkAb SAS
ArkAb SAS Medical SpecialtiesHealth Technology Part of Inoviem Scientific SAS, ArkAb SAS develops, manufactures, and commercializes raw materials for research in immunology and in vitro diagnostic market. The company is based in Limoges, France. The French company was founded in 2018. The CEO is Gaël Champier. | Health Technology |
B Cell Design SAS
B Cell Design SAS Miscellaneous Commercial ServicesCommercial Services B Cell Design SAS provides pharmaceutical services. It offers research and development services in producing antibodies. The firm serves as a platform for other diagnostic and pharmaceutical companies addressed to academic laboratories and industrial research. The company was founded in December 7, 2007 and is headquartered in Limoges, France. | Commercial Services |
